Junichi Mitsuyama Selected Research

garenoxacin

2/2014	Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
8/2012	In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis.
9/2011	In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junichi Mitsuyama Research Topics

Disease

10	Infections 01/2019 - 03/2002
3	Candidiasis (Moniliasis) 01/2019 - 04/2008
3	Body Weight (Weight, Body) 02/2015 - 09/2010
2	Sepsis (Septicemia) 01/2019 - 01/2019
2	Pneumococcal Infections 06/2017 - 07/2014
2	Invasive Candidiasis 03/2016 - 02/2015
2	Pneumonia (Pneumonitis) 02/2014 - 08/2007
2	Communicable Diseases (Infectious Diseases) 08/2012 - 09/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2017
1	Pneumococcal Pneumonia 02/2014
1	Human Influenza (Influenza) 02/2014
1	Malaria 04/2012
1	Bacterial Meningitis 08/2009
1	Cryptococcosis 04/2008
1	Aspergillosis 04/2008
1	Meningitis 04/2004
1	Necrosis 06/2003
1	Superinfection 06/2003
1	Calculi (Calculus) 08/2002
1	Soft Tissue Infections 03/2002
1	Burns 03/2002

Drug/Important Bio-Agent (IBA)

7	T-2307IBA 01/2019 - 04/2008
4	QuinolonesIBA 11/2017 - 03/2002
3	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2017 - 06/2003
3	garenoxacinIBA 02/2014 - 09/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2009 - 04/2004
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2003
2	Antifungal AgentsIBA 01/2019 - 06/2003
2	Conjugate VaccinesIBA 06/2017 - 07/2014
2	EchinocandinsIBA 03/2016 - 02/2015
2	FluoroquinolonesIBA 02/2014 - 07/2005
2	Therapeutic UsesIBA 02/2014 - 08/2002
2	Carbapenems (Carbapenem Antibiotics)IBA 10/2013 - 07/2005
2	Piperacillin FDA LinkGeneric 08/2007 - 04/2004
2	pazufloxacinIBA 07/2005 - 06/2003
2	Mesylates (Mesylate)IBA 06/2003 - 08/2002
1	Fluconazole (Zonal)FDA LinkGeneric 01/2017
1	Caspofungin (Cancidas)FDA Link 02/2015
1	Micafungin (FK463)FDA Link 04/2008
1	panipenemIBA 07/2005
1	Meropenem (Merrem)FDA LinkGeneric 07/2005
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2005
1	Imipenem FDA Link 07/2005
1	Ampicillin (Omnipen)FDA LinkGeneric 04/2004
1	beta-Lactamases (beta-Lactamase)IBA 04/2004
1	Adenosine Monophosphate (AMP)IBA 04/2004
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2004
1	Cefotaxime (Kendrick)FDA LinkGeneric 04/2004
1	Anti-Infective Agents (Microbicides)IBA 06/2003
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 06/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2002
1	T3912IBA 03/2002

Therapy/Procedure

2	Injections 04/2008 - 07/2005
1	Therapeutics 04/2004
1	Intravenous Administration 08/2002